TCM
TENX icon

Tang Capital Management’s Tenax Therapeutics TENX Stock Holding History

Tang Capital Management’s Portfolio TENX Stock Details TENX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-288
Closed -$708K – 18
2020
Q3 		$708K Hold
288
– – 0.13% 20
2020
Q2 		$416K Buy
+288
New +$424K 0.04% 21

Other funds holding TENX

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
FWP
FAS Wealth Partners Leawood, Kansas $1.92B AUM 26.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Tang Capital Management's TENX Position: Q4 2020 in Review

Tang Capital Management sold out of Tenax Therapeutics (TENX) in Q4 2020, closing a stake of 288 shares — an estimated $708K sold.

Tang Capital Management first reported a position in TENX in Q2 2020 and held it in 2 quarters. The position peaked at $708K in Q3 2020. 16 funds tracked by Wall St. Rank hold TENX as of Q4 2020.

  • Tang Capital Management reported no remaining Tenax Therapeutics position as of Q4 2020 after selling out during the quarter.
  • Tang Capital Management sold 288 Tenax Therapeutics shares in Q4 2020, an estimated $708K.
  • Tang Capital Management first reported a position in Tenax Therapeutics in Q2 2020 and held it in 2 quarters.
  • Tang Capital Management's Tenax Therapeutics position peaked at $708K in Q3 2020.
  • 16 funds tracked by Wall St. Rank held Tenax Therapeutics as of Q4 2020.

Based on Tang Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.